RESEARCH FUNDING
We've invested over 2 million dollars in preeclampsia research
Last Updated on May 06, 2024
RESEARCH FUNDING
Peter Joseph Pappas Research Grant Program
September 2024 - The 2025 Peter Joseph Pappas Research Grant LOI application process is currently closed.
Letters of Intent were to be submitted electronically via e-mail to PJPGrants@preeclampsia.org no later than Friday, August 30, 2024. We have closed the LOI period. Those invited by the scientific review committee and Preeclampsia Foundation's Board of Directors to submit full applications must do so by Wednesday, October 9, 2024. Award decisions will be rendered in December 2024. Winners will be announced in February 2025.
Named for the infant son of preeclampsia survivor Lauren Pappas and her husband Clement, the program seeks to award multiple grants totaling up to $200,000 each year. The ultimate goal of this grant program is to drive research that will eliminate the delivery of pre-term babies as an intervention for severe preeclampsia, HELLP syndrome, and related hypertensive disorders of pregnancy.
Read more about the Peter Joseph Pappas Research Grant Program.
Questions? Contact PJPGrants@preeclampsia.org
PREVIOUS PETER JOSEPH PAPPAS GRANT RECIPIENTS
The Vision Grant Award Program
May 2024 - The 2024 Vision Grant cycle is now closed.
Vision Grants are intended to provide initial funding for novel, innovative research by promising young investigators that will advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy. Post-doctoral, Clinical Fellows, or Early Stage Investigators only are eligible to apply. Projects with potential to alter clinical management and improve patient outcomes will receive priority, but any well-considered research proposal will be accepted for review. International applications are welcome; however, submissions must be in English. The Foundation has committed to funding grants that address known research knowledge gaps.
Questions? Contact VisionGrants@preeclampsia.org
PREVIOUS VISION GRANT RECIPIENTS
More Information
- Read final reports from our funded investigators, as well as the published results of our research, here.
- Sign up to receive immediate announcements about research funding and our monthly Research Roundup, here.
Researchers, please contact our Research Manager if you would like the Preeclampsia Foundation to help you recruit participants for a research study or focus group, or have any questions about the Preeclampsia Registry.
- 2024 Preeclampsia Foundation Vision Grant Awardees Announced
- 2023 Vision Grants
- 2022 Vision Grants
- 2019 Vision Grants
- 2018 Vision Grants
- 2017 Vision Grants
- 2016 Vision Grants
- 2015 Vision Grants
- 2014 Vision Grants
- 2013 Vision Grants
- 2012 Vision Grants
- 2011 Vision Grants
- 2010 Vision Grants
- 2009 Vision Grants
- 2008 Vision Grants
- 2007 Vision Grants
- 2002 Vision Grant
Related Articles
Your story is needed to improve outcomes for moms like you. Add your voice to critical preeclampsia research to ensure that every story is heard.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
1732072344.png)
While the Preeclampsia Foundation has been championing patient advocacy and representation for all families affected by hypertension in pregnancy throughout our 25 year history, we recognized the uniq...
Genetic predictors of blood pressure traits are associated with preeclampsia Although underlying causes of preeclampsia are not fully understood, there is evidence suggesting a strong genetic compone...
Hypertensive disorders of pregnancy (HDP) are a leading cause of maternal mortality and can put both mother and baby at risk for problems during pregnancy. Women who had HDPs have postpartum risk...
Elevated Blood Pressure in Pregnancy and Long-Term Cardiometabolic Health Outcomes This study looked at how elevated blood pressure during the third trimester of pregnancy affects cardiometabolic hea...
Planned early-term delivery in individuals with mild chronic hypertension was not associated with a reduction in adverse maternal outcomes but was associated with an increase in some neonatal complica...